Promega Corporation

AXL Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant human AXL (amino acids 473–end) was expressed by baculovirus in Sf9 insect cells using an N-terminal His tag. AXL is a member of the receptor tyrosine kinase family, which has oncogenic potential and is implicated in human myeloid leukemia. AXL is a member of a complex signaling network that is involved in the control of cell proliferation and differentiation. Overexpression of AXL cDNA in NIH/3T3 cells induces neoplastic transformation of these cells with the concomitant appearance of a 140kDa AXL tyrosine-phosphorylated protein. Expression of AXL cDNA in the baculovirus...

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for China customers only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart

AXL Kinase Enzyme System

Close Window

AXL Kinase Enzyme System

 Components

10μg
- V3961 ¥ 5,795.00 Add to cart

AXL Kinase Enzyme System

Close Window

AXL Kinase Enzyme System

 Components

1mg
- V3962 ¥ 71,143.00 Add to cart

ADP-Glo™ Kinase Assay + AXL Kinase Enzyme System

Close Window

ADP-Glo™ Kinase Assay + AXL Kinase Enzyme System

 Components

  • AXL Kinase Enzyme System

    V39611 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V9171 ¥ 8,713.00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V3961, V3962, V9171 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V9171 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V9171 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V9171 U.S. Pat. No. 7,741,067 and other patents and patents pending.

V9171 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V9171 U.S. Pat. No. 8,183,007 and other patents pending.

V9171 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V9171 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.